Adverse Effects of Combined Tyrosine Kinase Inhibitors

被引：0
|
作者：
Lu, Shun [1 ]
Li, Ziming [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 11期
关键词：
INTERSTITIAL LUNG-DISEASE; CANCER; C797S; GEFITINIB; T790M;
D O I：
10.1016/j.jtho.2020.07.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E182 / E183
页数：2
相关论文
共 50 条
  • [1] Letter to the Editor About the Adverse Effect of Combined Tyrosine Kinase Inhibitors
    Li, Zihui
    Deng, Jie
    Yan, Fei
    Ma, Yanling
    Sun, Jianhai
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (11) : E181 - E182
  • [2] Chemical suppression of adverse effects induced by EGFR tyrosine kinase inhibitors
    Nishiya, Naoyuki
    Oku, Yusuke
    Uehara, Yoshimasa
    CANCER SCIENCE, 2018, 109 : 749 - 749
  • [3] Combined effects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells
    Jin, Hyeon-Ok
    Hong, Sung-Eun
    Kim, Chang Soon
    Park, Jin-Ah
    Kim, Jin-Hee
    Kim, Ji-Young
    Kim, Bora
    Chang, Yoon Hwan
    Hong, Seok-Il
    Hong, Young Jun
    Park, In-Chul
    Lee, Jin Kyung
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2015, 287 (01) : 17 - 25
  • [4] The utility of a telemedicine platform to monitor adherence and adverse effects of tyrosine kinase inhibitors
    Copeland, Anureet C.
    Foster, Matthew C.
    Muluneh, Benyam
    Xenakis, James G.
    Ivanova, Anastasia
    Frankfurt, Olga
    Clayton, Monique
    Black, Anderson
    Rapchak, Barbara
    Wehbie, Robert S.
    LEUKEMIA & LYMPHOMA, 2019, 60 (07) : 1842 - 1844
  • [5] Cardiovascular adverse effects of Bruton tyrosine kinase inhibitors: Pathophysiological mechanisms, screening, and management
    Cautela, Jennifer
    Croizier, Carolyne
    Inchiappa, Luca
    Goncalves, Trecy
    Stocker, Nicolas
    Tchernonog, Emmanuelle
    BULLETIN DU CANCER, 2024, 111 (12) : 1142 - 1153
  • [6] PULMONARY ADVERSE EFFECTS OF SMALL MOLECULE TYROSINE KINASE INHIBITORS: A META-ANALYSIS
    Khoo, J.
    Barnes, H.
    Key, S.
    Glaspole, I
    Ostor, A.
    RESPIROLOGY, 2019, 24 : 71 - 71
  • [7] Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
    Sunder, Sunitha Shyam
    Sharma, Umesh C.
    Pokharel, Saraswati
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [8] Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
    Sunitha Shyam Sunder
    Umesh C. Sharma
    Saraswati Pokharel
    Signal Transduction and Targeted Therapy, 8
  • [9] TYROSINE KINASE INHIBITORS AND RENAL EFFECTS
    Turgut, Didem
    Yucel, Sebnem
    Bilgin, Burak
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 74 - 74
  • [10] Multitargeted molecules versus combined tyrosine kinase inhibitors
    Soria, J.
    Deutsch, E.
    Armand, J.
    EJC SUPPLEMENTS, 2006, 4 (12): : 13 - 14
12345